Overview

Violet Research Institute studies human genetic diseases by doing independent, primary research and openly sharing results to link basic science with medical treatments. It uses patient-zero research and a reusable infrastructure to accelerate progress across many conditions, especially in precision neurology, by integrating multiomics data (genomics, transcriptomics, clinical information) with computational biology and nanotechnology tools. Rather than selling a defined product, it partners with universities and biotech groups to translate findings into therapies and diagnostics. The institute distinguishes itself through open science, a broad focus on underlying biology beyond the label of “rare diseases,” and a collaborative, cross-disciplinary strategy guided by a Scientific Advisory Board. Its goal is to close the gap between scientific knowledge and medical applications, enabling faster development of treatments for genetic diseases.